Search Results
Improving the activity of BH3 mimetic venetoclax: a case study
Clinical trials investigating venetoclax combinations for AML
Venetoclax Resistance: Mechanisms and Treatment Options
Anderson MA (2013): Targeting Bcl-2 in the treatment of leukemia and lymphoma
CAVEAT: venetoclax and high dose chemo for elderly AML
Therapeutic potential of 5-Azacitidine plus various BH3 Mimetics in melanoma
Dr Anthony Letai: “Guiding drug and cell based cancer therapy with mitochondria”
Mechanisms and prospects of a novel CDK9 inhibitor
What's New in the Approach to DLBCL Upfront and in the Relapsed Setting Beyond CAR T
Bcl-2 Inhibition With ABT-199 in CLL, Lymphomas
Resistance mechanisms to FLT3 inhibitors in AML
Targeted proapoptotic drugs
